NovoCure Limited (NVCR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - NovoCure has developed, pioneered, and commercialized an effective wearable cancer therapy that is currently a standard of care [4] Leadership and Strategy - Frank Leonard, the new CEO with over 15 years at the company, emphasizes a focus on driving growth through a reorganization of the commercial organization [2][3] - The company is looking ahead to a catalyst-rich year in 2026, indicating multiple upcoming developments that could impact its growth trajectory [2][3]